Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simona Bratu

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|July 2, 2008
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York CitySimona Bratu, David Landman, Don Antonio Martin, et al.
Annals of Clinical Microbiology and Antimicrobials|December 2, 2006
A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York CitySimona Bratu, David Landman, Jyoti Gupta, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York CityDavid Landman, Elizabeth Babu, Neha Shah, et al.
Archives of Internal Medicine|June 29, 2005
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentariumSimona Bratu, David Landman, Robin Haag, et al.
The Journal of Antimicrobial Chemotherapy|May 27, 2005
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agentsSimona Bratu, Pooja Tolaney, Usha Karumudi, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York CityDavid Landman, Paul Kelly, Martin Bäcker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New YorkSimona Bratu, Steven Brooks, Sibte Burney, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2007
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NYDavid Landman, Simona Bratu, Sandeep Kochar, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2012
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustrationDavid Landman, Elizabeth Babu, Neha Shah, et al.
Journal of Clinical Microbiology|October 8, 2010
Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinityDavid Landman, Carl Urban, Martin Bäcker, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|July 2, 2008
Correlation of antimicrobial resistance with beta-lactamases, the OmpA-like porin, and efflux pumps in clinical isolates of Acinetobacter baumannii endemic to New York CitySimona Bratu, David Landman, Don Antonio Martin, et al.
Annals of Clinical Microbiology and Antimicrobials|December 2, 2006
A population-based study examining the emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 in New York CitySimona Bratu, David Landman, Jyoti Gupta, et al.
The Journal of Antimicrobial Chemotherapy|July 30, 2010
Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York CityDavid Landman, Elizabeth Babu, Neha Shah, et al.
Archives of Internal Medicine|June 29, 2005
Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentariumSimona Bratu, David Landman, Robin Haag, et al.
The Journal of Antimicrobial Chemotherapy|May 27, 2005
Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agentsSimona Bratu, Pooja Tolaney, Usha Karumudi, et al.
The Journal of Antimicrobial Chemotherapy|December 7, 2010
Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York CityDavid Landman, Paul Kelly, Martin Bäcker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 8, 2007
Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New YorkSimona Bratu, Steven Brooks, Sibte Burney, et al.
The Journal of Antimicrobial Chemotherapy|May 11, 2007
Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NYDavid Landman, Simona Bratu, Sandeep Kochar, et al.
The Journal of Antimicrobial Chemotherapy|March 2, 2012
Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustrationDavid Landman, Elizabeth Babu, Neha Shah, et al.
Journal of Clinical Microbiology|October 8, 2010
Susceptibility profiles, molecular epidemiology, and detection of KPC-producing Escherichia coli isolates from the New York City vicinityDavid Landman, Carl Urban, Martin Bäcker, et al.
Pageof 3